Platinum Quantum Dots and Their Cytotoxic Effect Towards Myoblast Cancer Cells (C2C12)

$113.00 plus tax (Refund Policy)

Buy Article:

Abstract:

The cytotoxic effect towards myoblast cancer cells (C2C12) of well-crystalline colloidal Pt quantum dots (QDs) was examined and presented in this paper. The Pt QDs were synthesized by facile colloidal process and characterized by transmission electron microscopy (TEM) and high-resolution TEM (HR-TEM), which confirmed that the QDs are prepared in high-density, possessing a well-crystalline structure. To examine the cytotoxicity, various doses of as-prepared QDs were treated with C2C12 myoblast cancer cells at different incubation intervals; 24, 48, 72, and 96 hours, and the viability of cells was analyzed with MTT assay. The detailed analyses revealed that in the presence of Pt-QDs, with increasing the incubation time, the number of cancer cells decreases. Moreover, with increasing concentration of Pt-QDs, the cancer cell death increases, confirming that the concentration of Pt-QDs has a significant role in controlling the number of cancer cells. The present research demonstrated that Pt-QDs can efficiently be used as anticancer agents.

Keywords: C2C12 MYOBLAST CANCER CELLS; MTT ASSAY; PT QUANTUM DOTS

Document Type: Research Article

DOI: http://dx.doi.org/10.1166/jbn.2012.1448

Publication date: June 1, 2012

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more